| Market Cap | 4.55B 4B 3.68B 3.45B 6.46B 431B 6.57B 44.22B 17.12B 211B 17.08B 16.71B 735B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.13B 3.8B 3.56B 6.67B 445B 6.78B 45.67B 17.68B 218B 17.64B 17.26B 759B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics
| 1 day | +1.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.57% | +1.65% | - | - | 4.55B | |
| +2.96% | +4.21% | -8.16% | -2.76% | 43.24B | |
| +2.58% | +8.79% | +325.45% | +567.52% | 35.25B | |
| +0.99% | +4.14% | +6.73% | +53.31% | 30.22B | |
| +2.14% | -4.37% | +10.42% | -19.96% | 28.01B | |
| -4.75% | -8.29% | +3.90% | +13.88% | 24.08B | |
| +3.72% | +2.47% | - | - | 14.16B | |
| +1.86% | +0.23% | +49.90% | +107.11% | 13.01B | |
| +2.77% | +4.02% | +9.61% | +15.31% | 12.7B | |
| +1.50% | +5.02% | +103.77% | +93.64% | 12.54B | |
| Average | +1.51% | -0.78% | +62.70% | +103.51% | 23.69B | |
| Weighted average by Cap. | +1.49% | -0.72% | +69.24% | +120.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 464M 428M 400M 750M 50.05B 763M 5.13B 1.99B 24.55B 1.98B 1.94B 85.34B | 634M 557M 513M 481M 900M 60.08B 916M 6.16B 2.39B 29.48B 2.38B 2.33B 102B |
| Net income | -56.11M -49.29M -45.42M -42.52M -79.66M -5.31B -81M -545M -211M -2.61B -211M -206M -9.06B | -27.11M -23.82M -21.95M -20.54M -38.49M -2.57B -39.14M -264M -102M -1.26B -102M -99.58M -4.38B |
| Net Debt | 194M 170M 157M 147M 275M 18.35B 280M 1.88B 729M 9B 727M 711M 31.29B | 149M 131M 120M 113M 211M 14.1B 215M 1.45B 560M 6.92B 559M 547M 24.04B |
Employees
-
